Rozrolimupab, amixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia

Authors
Category Primary study
JournalBlood
Year 2012
This article has no abstract
Epistemonikos ID: 997d74ae4f3cc8ca49ecb3bb2c53a5ee467535c1
First added on: Nov 19, 2023